Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis.

Mrabet-Dahbi S, Dalpke AH, Niebuhr M, Frey M, Draing C, Brand S, Heeg K, Werfel T, Renz H.

J Allergy Clin Immunol. 2008 Apr;121(4):1013-9. doi: 10.1016/j.jaci.2007.11.029.

PMID:
18234309
2.

Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy.

Bochud PY, Hawn TR, Siddiqui MR, Saunderson P, Britton S, Abraham I, Argaw AT, Janer M, Zhao LP, Kaplan G, Aderem A.

J Infect Dis. 2008 Jan 15;197(2):253-61. doi: 10.1086/524688.

3.

Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.

Chen YC, Giovannucci E, Kraft P, Lazarus R, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1982-9.

4.

Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.

Cerhan JR, Ansell SM, Fredericksen ZS, Kay NE, Liebow M, Call TG, Dogan A, Cunningham JM, Wang AH, Liu-Mares W, Macon WR, Jelinek D, Witzig TE, Habermann TM, Slager SL.

Blood. 2007 Dec 15;110(13):4455-63.

5.

Toll-like receptors in inflammation, infection and cancer.

Chen K, Huang J, Gong W, Iribarren P, Dunlop NM, Wang JM.

Int Immunopharmacol. 2007 Oct;7(10):1271-85. Review.

PMID:
17673142
6.

A common human TLR1 polymorphism regulates the innate immune response to lipopeptides.

Hawn TR, Misch EA, Dunstan SJ, Thwaites GE, Lan NT, Quy HT, Chau TT, Rodrigues S, Nachman A, Janer M, Hien TT, Farrar JJ, Aderem A.

Eur J Immunol. 2007 Aug;37(8):2280-9.

7.

Marginal-zone lymphoma.

Ferreri AJ, Zucca E.

Crit Rev Oncol Hematol. 2007 Sep;63(3):245-56. Review.

PMID:
17583528
8.

Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy.

Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin O, Alpsoy E, Hamann L, Schumann RR, Tapping RI.

J Immunol. 2007 Jun 15;178(12):7520-4.

9.

The polymorphism P315L of human toll-like receptor 1 impairs innate immune sensing of microbial cell wall components.

Omueti KO, Mazur DJ, Thompson KS, Lyle EA, Tapping RI.

J Immunol. 2007 May 15;178(10):6387-94.

10.

Characterization and investigation of single nucleotide polymorphisms and a novel TLR2 mutation in the human TLR2 gene.

Merx S, Neumaier M, Wagner H, Kirschning CJ, Ahmad-Nejad P.

Hum Mol Genet. 2007 May 15;16(10):1225-32.

11.

Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).

Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadié M, Spinelli JJ, Costantini AS, Rüdiger T, Scarpa A, Zheng T, Weisenburger DD.

Blood. 2007 Jul 15;110(2):695-708.

12.

Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.

Ramos-Casals M, la Civita L, de Vita S, Solans R, Luppi M, Medina F, Caramaschi P, Fadda P, de Marchi G, Lopez-Guillermo A, Font J; SS-HCV Study Group..

Arthritis Rheum. 2007 Feb 15;57(1):161-70.

13.

Toll like receptors and viruses.

Finberg RW, Wang JP, Kurt-Jones EA.

Rev Med Virol. 2007 Jan-Feb;17(1):35-43. Review.

PMID:
17146842
14.

Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.

Purdue MP, Lan Q, Kricker A, Grulich AE, Vajdic CM, Turner J, Whitby D, Chanock S, Rothman N, Armstrong BK.

Carcinogenesis. 2007 Mar;28(3):704-12.

15.

Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.

Wang SS, Cerhan JR, Hartge P, Davis S, Cozen W, Severson RK, Chatterjee N, Yeager M, Chanock SJ, Rothman N.

Cancer Res. 2006 Oct 1;66(19):9771-80.

16.

Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk.

Nieters A, Beckmann L, Deeg E, Becker N.

Genes Immun. 2006 Dec;7(8):615-24.

PMID:
16971956
17.

Resampling-based multiple hypothesis testing procedures for genetic case-control association studies.

Chen BE, Sakoda LC, Hsing AW, Rosenberg PS.

Genet Epidemiol. 2006 Sep;30(6):495-507.

PMID:
16755536
18.

Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma.

Forrest MS, Skibola CF, Lightfoot TJ, Bracci PM, Willett EV, Smith MT, Holly EA, Roman E.

Br J Haematol. 2006 Jul;134(2):180-3.

PMID:
16740140
19.

TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation.

Kesh S, Mensah NY, Peterlongo P, Jaffe D, Hsu K, VAN DEN Brink M, O'reilly R, Pamer E, Satagopan J, Papanicolaou GA.

Ann N Y Acad Sci. 2005 Dec;1062:95-103.

PMID:
16461792
20.

Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma.

Lan Q, Zheng T, Rothman N, Zhang Y, Wang SS, Shen M, Berndt SI, Zahm SH, Holford TR, Leaderer B, Yeager M, Welch R, Boyle P, Zhang B, Zou K, Zhu Y, Chanock S.

Blood. 2006 May 15;107(10):4101-8.

Items per page

Supplemental Content

Support Center